In terms of types of therapies, sonodynamic and chemodynamic therapies appear to be emerging at a rapid rate along with RNA based vaccines with publications tripling over the last three years (Fig. ). Concepts such as chimeric antigen receptor T cell (CAR-T) therapy, nanovaccines, kinase inhibitors including HPK1 and FLT3 inhibitors, among others are also growing at a fairly rapid rate (Fig. ). Examples of therapies growing at a modest pace include anti-HER2 ADCs, dendritic cell activators, HDAC inhibitors, and PI3K inhibitors (Fig. ).